Search published articles


Showing 2 results for Doosti Irani

Amin Doosti Irani, Batool Okhovat, Zahra Cheraghi, Mozhgan Talaei, Elham Ahmadnezhad, Mohammad Mehdi Gooya, Mohammad Soroosh, Hossein Masoumi Asl, Kourosh Holakoie Naieni,
Volume 12, Issue 2 (10-2014)
Abstract

  Background and Aim: Water and food born diseases are one of the important causes of morbidity and mortality in through the world. The objective of this study was to investigate factors affecting the persistence of diarrheal cases after the explosive epidemic phase of diarrheal disease in Yazd province.

  Materials and Methods: We designed a match case control study that was performed on base of incidence cases of diarrhea since 24 Aug, 2013 to 03 Sept, 2013.Characteristics of cases and control were obtained by interviewers using a pre-determined questionnaire. Logistic regression was used at 0.05 significant level.

  Results: Totally 69 incidences cases of diarrhea were compared with 138 controls. Incidence rate of diarrhea in Yazd province was 13.79 per thousand. The adjusted odds ratio estimate for presence a patient stricken with gastroenteritis in the household was 3.63 [95% CI: 1.43, 9.20]. The adjusted odds ratio for low education, history of the trip, history of contact with patient and eating outside the home were 1.75, 1.55, 1.93 and 1.37 respectively, that increase odds of disease but their effects was not statistically significant.

  Conclusion: In this study the most important risk factor for diarrhea was history of contact with the person with the disease in the household. This result may indicate the lack of personal hygiene by patients and their relatives and thus transmission of disease to others peoples. Therefore the role of health education and informing about transmission and preventive ways is very important in prevention and control of outbreaks of diarrhea diseases.


Mina Morsali, Amin Doosti Irani,
Volume 20, Issue 4 (3-2023)
Abstract

Background and Aim: So far various medicinal treatments have been introduced to treat obesity. In this study we compared the available drugs for the treatment of obesity in women with polycystic ovary syndrome (PCOS).
Materials and Methods: This study was conducted using systematic review and network meta-analysis (NMA) methods. The major international databases including PubMed, Web of Science, Scopus, Cochrane Library and Embase were searched, the search ending in March 2022. Only randomized controlled trials (RCTs) comparing medicinal interventions in women with PCOS were included in the study. Two of the researchers were responsible for screening the retrieved sources. The Cochrane tool was used to assess the risk of bias. The loop-specific and design by treatment interaction approaches were used to assess the consistency assumption. Treatments in each network were ranked using the P-score. The random effects model was used to report the results. The results were reported at %95 confidence interval (CI). I2 statistic was used to check the heterogeneity of the studies.
Results: Out of the 9335 retrieved references, 9 studies met the eligibility criteria. There were two networks for the treatment of obesity in women with polycystic ovary syndrome: Liraglutide (1.2), [P-score=0.86, MD=-8.02(-20.99, 4.94)] as the best treatment in the first network, and Orlistat (120), [P-score=0.88, MD=-3.49 (-5.17, -1.81)] as the best treatment in the second network.
Conclusion: Based on the results of network meta-analysis, it seems that the best medicinal interventions for obesity in women with polycystic syndrome rare Liraglutide (1.2) and Orlistat (120).
 

Page 1 from 1     

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb